Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M Stivland

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 11, 2019
Advancing electrophysiology: partnerships achieve meaningful innovationKenneth M Stein, Matthew S Sulkin, Timothy M Stivland
BMJ Open|October 28, 2021
Response to cardiac resynchronisation therapy in men and women: a secondary analysis of the SMART-AV randomised controlled trialStacey Howell, Timothy M Stivland, Kenneth Stein, et al.
JACC. Clinical Electrophysiology|December 24, 2021
REPLY: Reshaping Patient Outcomes With Machine LearningLarisa G Tereshchenko, Stacey J Howell, Timothy M Stivland, et al.
JACC. Clinical Electrophysiology|May 26, 2018
Impact of Body Mass Index on Safety and Efficacy of the Subcutaneous Implantable Cardioverter-DefibrillatorDavid S Frankel, Martin C Burke, David J Callans, et al.
JACC. Heart Failure|February 10, 2020
Association of Implantable Device Measured Physical Activity With Hospitalization for Heart FailureJacob P Kelly, Nicholas G Ballew, Li Lin, et al.
European Heart Journal|January 28, 2022
Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS studyPier D Lambiase, Dominic A Theuns, Francis Murgatroyd, et al.
Heart Rhythm|November 29, 2016
Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indicationLucas V Boersma, Craig S Barr, Martin C Burke, et al.
Heart Rhythm|May 16, 2017
Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative resultsMichael R Gold, Johan D Aasbo, Mikhael F El-Chami, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Disparities in Utilization of Advanced Structural Heart Cardiovascular TherapiesAndrew M Goldsweig, Megan Coylewright, Ramesh Daggubati, et al.
Heart Rhythm|April 22, 2021
Device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patientsMikhael F El-Chami, Caroline M Jacobsen, Robert I Griffiths, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 11, 2019
Advancing electrophysiology: partnerships achieve meaningful innovationKenneth M Stein, Matthew S Sulkin, Timothy M Stivland
BMJ Open|October 28, 2021
Response to cardiac resynchronisation therapy in men and women: a secondary analysis of the SMART-AV randomised controlled trialStacey Howell, Timothy M Stivland, Kenneth Stein, et al.
JACC. Clinical Electrophysiology|December 24, 2021
REPLY: Reshaping Patient Outcomes With Machine LearningLarisa G Tereshchenko, Stacey J Howell, Timothy M Stivland, et al.
JACC. Clinical Electrophysiology|May 26, 2018
Impact of Body Mass Index on Safety and Efficacy of the Subcutaneous Implantable Cardioverter-DefibrillatorDavid S Frankel, Martin C Burke, David J Callans, et al.
JACC. Heart Failure|February 10, 2020
Association of Implantable Device Measured Physical Activity With Hospitalization for Heart FailureJacob P Kelly, Nicholas G Ballew, Li Lin, et al.
European Heart Journal|January 28, 2022
Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS studyPier D Lambiase, Dominic A Theuns, Francis Murgatroyd, et al.
Heart Rhythm|November 29, 2016
Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indicationLucas V Boersma, Craig S Barr, Martin C Burke, et al.
Heart Rhythm|May 16, 2017
Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative resultsMichael R Gold, Johan D Aasbo, Mikhael F El-Chami, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Disparities in Utilization of Advanced Structural Heart Cardiovascular TherapiesAndrew M Goldsweig, Megan Coylewright, Ramesh Daggubati, et al.
Heart Rhythm|April 22, 2021
Device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patientsMikhael F El-Chami, Caroline M Jacobsen, Robert I Griffiths, et al.
Pageof 1